MELISSA KESTLER: Open Payments
NPI 1255988770 · SEAFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 33 payments from 11 companies in 2025. Trend: 2023 $1,790 · 2024 $1,865 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $419 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $166 |
| ABBVIE INC. | 4 | $85 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| COLOPLAST CORP | 2 | $39 |
| Astellas Pharma US Inc | 2 | $35 |
| Endo USA, Inc. | 2 | $32 |
Products named: ERLEADA, Nubeqa, RYBREVANT, PYLARIFY, KEYTRUDA, BOTOX, PLUVICTO, SpeediCath.
Industry payments across DE — which companies pay providers there.
